Y.S.P.SOUTHEAST ASIA HOLDING
KLSE (MYR): YSPSAH (7178)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
2.08
Today's Change
+0.01 (0.48%)
Day's Change
2.05 - 2.08
Trading Volume
16,300
Overview
Market Cap
293 Million
NOSH
141 Million
Avg Volume (4 weeks)
56,920
4 Weeks Range
1.91 - 2.13
4 Weeks Price Volatility (%)
77.27%
52 Weeks Range
1.88 - 2.39
52 Weeks Price Volatility (%)
39.22%
Previous Close
2.08
Open
2.06
Bid
2.06 x 1,000
Ask
2.09 x 1,000
Day's Range
2.05 - 2.08
Trading Volume
16,300
Financial Highlight
Latest Quarter | Ann. Date
31-Mar-2022 [#1] | 20-May-2022
Next QR | Est. Ann. Date
30-Jun-2022 | 20-Aug-2022
T4Q P/E | EY
15.52 | 6.45%
T4Q DY | Payout %
3.81% | 59.09%
T4Q NAPS | P/NAPS
2.50 | 0.83
T4Q NP Margin | ROE
6.49% | 5.37%
Market Buzz
News and Blogs
No result.
Company Profile
Sector: HEALTH CARE
Sector: HEALTH CARE
Subsector: PHARMACEUTICALS
Subsector: PHARMACEUTICALS
Description:
Y SP Southeast Asia Holding Bhd is an investment company, which engages in the pharmaceutical business, provision of management services. It operates through the following segments: Trading, Manufacturing and Investment Holding. The Trading segment imports, exports, and trades various kinds of pharmaceutical products. The Manufacturing segment manufactures pharmaceutical products. The Investment Holding segment focuses on investment holding activity. Firm?s majority revenue comes from the Manufacturing segment. Its majority revenue is concentrated in Malaysia.
Discussions
5 people like this. Showing 50 of 2,044 comments
As per 2019 annual report
Cash & Cash equivalent : RM 90,083,000
Less Loan & Borrowings : RM 28,831,000 + RM 9,915,000
So net cash now : RM 51,337,000
** Don't simply tembak
2020-08-26 10:22
good counter to invest no matter long term or short term, long term invest to earn dividend compared bank interest which lower now. short term invest if vaccine is available, investor favor hearth care counter
2020-08-26 11:10
永信藥品聚焦重症感染藥物
今年營運續增6%
永信藥品聚焦發展重症感染藥物，深化自原料藥至製劑垂直整合技術能力；今年因應疫情衝擊拉高原料庫存，原料成本均上揚，全年業績仍可望拚6%成長，維持穩定成長趨勢。
永信藥品今年由於疫情關係，各國對於抗疫物資的出口已相對保守，原物料供應鏈不若以往寬鬆，為確保生產線供貨穩定，避免來自中國大陸的料缺貨，去年底已陸續將原料存量拉高35%，目前外銷市場及內銷市場約2比8，每年成長6%的目標不變，各個品項成長動能均衡。
永信為全球少數擁有生物醱酵、化學合成技術以及藥品處方快篩技術綜合型藥廠。
近年來，由於抗生素的廣泛使用而產生抗藥性細菌，對病患健康產生重大威脅。
過去由於注射型抗黴菌藥物藥價昂貴、與臨床使用上的安全性問題，限制了病患的用藥時機與療程。
永信針對感染性疾病，持續深耕發展抗感染藥物，除了早期開發的廣效型抗生素藥物、中期發展預防性黴菌感染與抗病毒藥物，近期更朝向需求日增的重症感染領域，目前已經成功開發3項產品。
其中與台微體攜手合作，掌握特殊奈米化微脂體劑型的關鍵製程，已成功量產Amphotericin B （微脂體製劑），目前正配合進行歐、美、中等大型市場的查登作業。
2020-09-03 10:02
Taiwanese new special medicine Silmitasertib (CX-4945) cured covid 19 in 5 days time.
http://www.senhwabiosciences.com/tw/new?cls=1491881153&guid=159910...
2020-09-03 14:15
United States vaccine failed!
The glove unit ESCERAM 0100 is about to fly!
2020-09-17 09:34
Sinopharm Vaccine (linked to Kanger) is on track for full approval in November or December
“The most promising of these, developed by Wuhan-based Sinopharm, is already being given to frontline workers in the United Arab Emirates. According to Wu Guizhen, chief biosafety expert at the Chinese Center for Disease Control and Prevention, Sinopharm’s candidate is on track for full approval this month or next.”
https://www.foreignaffairs.com/articles/united-states/2020-11-05/china...
2020-11-07 02:29
China National Pharmaceutical Group Corp (SINOPHARM), a Chinese state-owned enterprise, announced on Wednesday that data from late-stage clinical trials for its Covid-19 vaccine are «BETTER THAN EXPECTED», Reuters reported.
In Morocco, Dr. Abdelhakim Yahyane, a member of the National Scientific Advisory Committee on Vaccination, told Yabiladi earier this week that vaccine trials in the country «have REACHED THE FINAL PHASE».
We are impatiently awaiting the end of this process, which could probably happen BY NEXT WEEK
https://en.yabiladi.com/articles/details/101544/conducted-morocco-amon...
2020-11-13 21:53
PM: No call to reject 2021 Budget just to bring about polls
"There is no need to do that (reject the 2021 Budget). If you ask me, I could have yesterday advised the Yang di-Pertuan Agong Al-Sultan Abdullah Ri'ayatuddin Al-Mustafa Billah Shah, to dissolve Parliament so that a general election can be held.
"But we all know that the problem is Covid-19. InsyaAllah, if He allows it, when the pandemic is over, we can hold a general election.
Muhyiddin added that the 2021 Budget, worth RM322.5 billion which was passed at the policy level in Parliament on Thursday, is aimed at easing the burden of the people and restoring the country's economy.
"I hope the 2021 Budget will be approved at the Dewan Rakyat and subsequently at the Dewan Negara. This is to ensure that the people will receive the assistance that they need during this tough time."
https://www.nst.com.my/news/politics/2020/11/645117/pm-no-call-reject-...
2020-11-29 21:26
No significant change to reject budget at committee level: Dr M
FORMER Prime Minister (PM) Tun Dr Mahathir Mohamad said no significant change can be achieved if the proposed Budget 2021 is rejected at the committee level debate session.
“Rejecting the budget at the committee level, as it is said to be done, will not bring any significant impact on the government nor the proposed budget.
“It is just an attempt to divert the criticisms of the people who are disappointed with the attitude of the Opposition,” Dr Mahathir said in a statement today.
https://themalaysianreserve.com/2020/11/27/no-significant-change-to-re...
2020-11-29 21:36
UAE says Sinopharm vaccine has 86% efficacy against COVID-19
DUBAI (Reuters) - An experimental coronavirus vaccine developed by China’s Sinopharm has 86% efficacy against the virus, the United Arab Emirates health ministry said on Wednesday, citing an interim analysis of a human trial underway there.
The Gulf Arab state in July started Phase 3 clinical trials of the vaccine, developed by Beijing Institute of Biological Product, a unit of Sinopharm’s China National Biotec Group (CNBG). In September, the UAE approved its emergency use for certain groups.
The analysis also shows “99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of the disease”, the ministry said in a statement carried by the state news agency.
“The analysis shows no serious safety concerns,” it said.
It also said it had officially registered the vaccine, without elaborating, and that 31,000 volunteers across 125 nationalities participated in the UAE trial.
https://www.reuters.com/article/health-coronavirus-emirates/update-1-u...
2020-12-09 15:17
United Arab Emirates Claims China’s Sinopharm Vaccine Is 100% Effective At Preventing Moderate And Severe Covid-19
TOPLINE The experimental vaccine developed by China National Pharmaceutical Group, also known as Sinopharm, is 86% effective at preventing Covid-19 infection and 100% effective at preventing severe and moderate disease, health officials from the United Arab Emirates announced Wednesday, although with scarce detail provided about the trial.
The UAE health ministry cited an interim analysis of a late-stage clinical trial involving 31,000 volunteers as the source of its information, though neither they nor Sinopharm provided any data from the trial to validate the claims such as how many participants were infected or how many actually received the vaccine.
The ministry said “no serious safety concerns” were observed, though, again, no information on side effects was provided.
The ministry said the announcement is a “significant vote of confidence by the UAE’s health authorities in the safety and efficacy of this vaccine.”
The ministry added that it had officially registered the vaccine at the request of the manufacturer, which it says could eventually lead to the shot’s widespread authorization.
https://www.forbes.com/sites/roberthart/2020/12/09/united-arab-emirate...
2020-12-09 22:24
why so many people keep posting the same vaccine news all over the place? cannot ban them?
here we want to know whether yspsah got vaccine or not
2020-12-10 22:01
A Guide to Investing in Healthcare Companies
Low tier: IHH, TopGlove, Supermaxm Pharmaniaga
High tier: YSPSAH, Apex Healthcare, Duopharma
2021-06-10 15:03
This is super cheap. Dividend announcement is 8 cents, current price means this is 4% ROI. NTA is well above 2.40. I just parked my orders to buy in, this is a really good steal.
2021-07-14 09:51
Nothing much to comment about this stock.Sold some last year.Should have sold all. Dividen is nothing to shout about.
2021-08-29 19:11
gamblers ? i thought most of us will forget we owned this stock until we received a cheque notice about the dividend . hahaha
2021-09-01 16:19
As i mentioned, hold long term for good profit
Refered to my message on 30/8/21
2021-09-01 16:59
Hold for lomg term.
2 years like that.
You will thanks me.
Just a cup of starbuck belanja me.
2021-09-22 11:31
Guide to Investing in Bursa Healthcare 2022
1. Kotra Industries 2. YSP 3. ???
2022-04-02 21:53
Post a Comment
Featured Posts
1
I3investor
2
MQ Trader Announcement!
MQ Trading Signals
Time
Signal
Duration
Type
2022-08-18 16:43:20
EMA 5
Hourly
BUY
2022-08-18 09:53:34
EMA 5
10 Mins
SELL
2022-08-18 09:53:34
ADX
10 Mins
SELL
2022-08-18 09:53:34
TURTLE SYSTEM 20
10 Mins
SELL
2022-08-18 09:14:24
ADX
30 Mins
SELL
Apps
Top Articles
1
Koon Yew Yin's Blog
2
Koon Yew Yin's Blog
3
Good Articles to Share
4
Koon Yew Yin's Blog
5
6
Good Articles to Share
India backtracks on support for Rohingya refugees, will deport them
7
8
James的股票投资James Share Investing
[转贴] [Video:浅谈HARTALEGA HOLDINGS BERHAD, HARTA, 5168] - James的股票投资James Share Investing
Hot Stocks Today
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
ShareNews
wah...this company rich of CASH of 104mils...almost 74sen per share with low borrowings. BUY BUY BUY
2020-08-26 10:18